Your session is about to expire
← Back to Search
Integrated PTSD & Nightmare Therapy for Post-Traumatic Stress Disorder (CPTERRT Trial)
N/A
Recruiting
Led By Joanne l Davis, PhD
Research Sponsored by University of Tulsa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
meet full criteria for PTSD
18 Years of Age minimal
Timeline
Screening 3 weeks
Treatment Varies
Follow Up past month symptoms measured at baseline, and 3 and 6 month follow-up
Awards & highlights
CPTERRT Trial Summary
This trial is studying a possible new treatment for PTSD that integrates exposure, relaxation, and rescripting therapy with cognitive processing therapy.
Who is the study for?
This trial is for adults who have experienced trauma, suffer from PTSD with at least one nightmare per week over the past month. It's not suitable for individuals under 18, those with active suicidal thoughts, recent substance abuse disorders, acute psychosis, bipolar disorder or intellectual disability.Check my eligibility
What is being tested?
The study tests if combining two therapies—Cognitive Processing Therapy (CPT) and Exposure, Relaxation and Rescripting Therapy (ERRT)—is more effective for treating PTSD and related nightmares than CPT alone. Participants will receive either both treatments in sequence or just CPT.See study design
What are the potential side effects?
Potential side effects may include increased distress due to recalling traumatic events during therapy sessions. As these are psychological interventions rather than medications, traditional physical side effects are not expected.
CPTERRT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with PTSD.
Select...
I am at least 18 years old.
CPTERRT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ past month symptoms measured at baseline, and 3 and 6 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~past month symptoms measured at baseline, and 3 and 6 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Nightmare Frequency
Secondary outcome measures
Clinician Administered PTSD Scale
CPTERRT Trial Design
3Treatment groups
Active Control
Group I: Cognitive Processing Therapy-CognitiveActive Control1 Intervention
12 sessions of cognitive processing therapy-Cognitive
Group II: CPT-C + ERRTActive Control2 Interventions
12 sessions of Cognitive Processing Therapy - Cognitive, followed by 5 sessions of Exposure, Relaxation, and Rescripting Therapy
Group III: ERRT + CPT-CActive Control2 Interventions
5 sessions of Exposure, Relaxation, and Rescripting Therapy, followed by 12 sessions of Cognitive Processing Therapy- Cognitive
Find a Location
Who is running the clinical trial?
University of TulsaLead Sponsor
15 Previous Clinical Trials
10,735 Total Patients Enrolled
Joanne l Davis, PhDPrincipal InvestigatorUniversity of Tulsa
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 17 years old or younger.You have had a recent injury or accident.I have been diagnosed with PTSD.You are currently experiencing thoughts or behaviors related to wanting to harm yourself.You have been diagnosed with bipolar disorder.I am at least 18 years old.You are currently experiencing a severe mental condition called acute psychosis.You have experienced at least one bad dream every week for the past month, with the least amount possible.You have not received treatment for drug or alcohol addiction in the past 6 months.You have a condition that affects your ability to think and learn.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Processing Therapy-Cognitive
- Group 2: CPT-C + ERRT
- Group 3: ERRT + CPT-C
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently taking part in this research endeavor?
"Correct. Records available on clinicaltrials.gov verify that this medical trial, which was initially advertised on August 1st 2014, is still recruiting patients. 90 participants need to be sourced from a single location for the experiment's completion."
Answered by AI
Are there still openings for participants in this trial?
"Affirmative, the information hosted on clinicaltrials.gov affirms that this medical trial is actively enrolling participants. This research initiative was initially posted on August 1st 2014 and most recently updated in May 24th 2022. Its goal is to recruit a total of 90 subjects from one particular site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger